Klaus Dinkel

Klaus is CEO of CalTIC GmbH and Head of Project Management at LDC GmbH. He is a neuroimmunologist with over 15 years of experience in the pharmaceutical industry as department head, project leader and project manager in drug research and development. Before moving to the LDC, he was working for Jerini AG Berlin (now Shire) and FAN GmbH. He did a post-doc at Stanford University (Prof. R.M. Sapolsky) and was a PhD student in human biology at the University of Ulm/Heidelberg. He has authored over 20 peer-reviewed publications in high-impact journals in the field of inflammation and CNS immunology.